Laboratorios Aspen is proud to introduce its new product Vemer® (Sevelamer), intended for the treatment of hyperphosphatemia, which is added to the “Nephrology” division.
Indications:
It is indicated for the control of hyperphosphatemia in adult patients receiving hemodialysis or peritoneal dialysis.
Presentation:
Package containing 180 coated tablets.